Edition:
United States

Prophase Labs Inc (PRPH.OQ)

PRPH.OQ on NASDAQ Stock Exchange Capital Market

3.01USD
18 Jul 2018
Change (% chg)

$-0.02 (-0.66%)
Prev Close
$3.03
Open
$3.01
Day's High
$3.01
Day's Low
$3.01
Volume
217
Avg. Vol
7,451
52-wk High
$6.63
52-wk Low
$2.01

Chart for

About

ProPhase Labs, Inc. manufactures, markets and distributes a range of homeopathic and healthcare products. The Company is engaged in the research and development of over-the-counter (OTC) drugs and natural base health products, including supplements, personal care and cosmeceutical products. The Company's products include TK... (more)
No analyst recommendations are available for .

Overall

Beta: 0.00
Market Cap(Mil.): $33.72
Shares Outstanding(Mil.): 11.13
Dividend: 1.00
Yield (%): --

Financials

  PRPH.OQ Industry Sector
P/E (TTM): -- 20.64 39.24
EPS (TTM): -0.03 -- --
ROI: -2.25 10.70 46.41
ROE: -2.25 14.47 54.23

BRIEF-Prophase Labs Quarterly Sales $3.4 Million Versus $771,000

* PROPHASE LABS REPORTS FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2018

May 15 2018

BRIEF-Prophase Labs Announces Special Cash Dividend

* BOARD OF DIRECTORS HAS DECLARED A SPECIAL CASH DIVIDEND IN AMOUNT OF $1.00 PER SHARE ON ITS COMMON STOCK Source text for Eikon: Further company coverage:

May 07 2018

BRIEF-Prophase Labs Announces New Compensatory Arrangement With CEO And Termination Of Stockholder Rights Plan

* PROPHASE LABS, INC. ANNOUNCES NEW COMPENSATORY ARRANGEMENT WITH CHIEF EXECUTIVE OFFICER AND TERMINATION OF STOCKHOLDER RIGHTS PLAN

Feb 20 2018

Earnings vs. Estimates

No consensus analysis data available.